-
1
-
-
0028069915
-
Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries
-
Adner M, Jansen I, Edvinsson L, (1994). Endothelin-A receptors mediate contraction in human cerebral, meningeal and temporal arteries. J Auton Nerv Syst 49 (Suppl.): S117-S121.
-
(1994)
J Auton Nerv Syst
, vol.49
, pp. S117-S121
-
-
Adner, M.1
Jansen, I.2
Edvinsson, L.3
-
2
-
-
0032481287
-
Novel selective quinazoline inhibitors of endothelin converting enzyme-1
-
Ahn K, Sisneros AM, Herman SB, Pan SM, Hupe D, Lee C, et al. (1998). Novel selective quinazoline inhibitors of endothelin converting enzyme-1. Biochem Biophys Res Commun 243: 184-190.
-
(1998)
Biochem Biophys Res Commun
, vol.243
, pp. 184-190
-
-
Ahn, K.1
Sisneros, A.M.2
Herman, S.B.3
Pan, S.M.4
Hupe, D.5
Lee, C.6
-
3
-
-
84890503612
-
The concise guide to PHARMACOLOGY 2013/14: G protein-coupled receptors
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013a). The concise guide to PHARMACOLOGY 2013/14: G protein-coupled receptors. Br J Pharmacol 170: 1459-1581.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1459-1581
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
4
-
-
84890472386
-
The concise Guide to PHARMACOLOGY 2013/14: Enzymes
-
Alexander SPH, Benson HE, Faccenda E, Pawson AJ, Sharman JL, Spedding M, et al. (2013b). The concise Guide to PHARMACOLOGY 2013/14: Enzymes. Br J Pharmacol 170: 1797-1867.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1797-1867
-
-
Alexander, S.P.H.1
Benson, H.E.2
Faccenda, E.3
Pawson, A.J.4
Sharman, J.L.5
Spedding, M.6
-
5
-
-
84872875918
-
Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor
-
Allard B, Wijkhuisen A, Borrull A, Deshayes F, Priam F, Lamourette P, et al. (2013). Generation and characterization of rendomab-B1, a monoclonal antibody displaying potent and specific antagonism of the human endothelin B receptor. MAbs 5: 56-69.
-
(2013)
MAbs
, vol.5
, pp. 56-69
-
-
Allard, B.1
Wijkhuisen, A.2
Borrull, A.3
Deshayes, F.4
Priam, F.5
Lamourette, P.6
-
6
-
-
0025605345
-
Cloning and expression of a cDNA encoding an endothelin receptor
-
Arai H, Hori S, Aramori I, Ohkubo H, Nakanishi S, (1990). Cloning and expression of a cDNA encoding an endothelin receptor. Nature 348: 730-732.
-
(1990)
Nature
, vol.348
, pp. 730-732
-
-
Arai, H.1
Hori, S.2
Aramori, I.3
Ohkubo, H.4
Nakanishi, S.5
-
7
-
-
33747603873
-
Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt
-
Bagnall AJ, Kelland NF, Gulliver-Sloan F, Davenport AP, Gray GA, Yanagisawa M, et al. (2006). Deletion of endothelial cell endothelin B receptors does not affect blood pressure or sensitivity to salt. Hypertension 48: 286-293.
-
(2006)
Hypertension
, vol.48
, pp. 286-293
-
-
Bagnall, A.J.1
Kelland, N.F.2
Gulliver-Sloan, F.3
Davenport, A.P.4
Gray, G.A.5
Yanagisawa, M.6
-
8
-
-
79954456308
-
Role of the endothelin axis and its antagonists in the treatment of cancer
-
Bagnato A, Loizidou M, Pflug BR, Curwen J, Growcott J, (2011). Role of the endothelin axis and its antagonists in the treatment of cancer. Br J Pharmacol 163: 220-233.
-
(2011)
Br J Pharmacol
, vol.163
, pp. 220-233
-
-
Bagnato, A.1
Loizidou, M.2
Pflug, B.R.3
Curwen, J.4
Growcott, J.5
-
9
-
-
10744230817
-
Sitaxsentan therapy for pulmonary arterial hypertension
-
Barst RJ, Langleben D, Frost A, Horn EM, Oudiz R, Shapiro S, et al. (2004). Sitaxsentan therapy for pulmonary arterial hypertension. Am J Respir Crit Care Med 169: 441-447.
-
(2004)
Am J Respir Crit Care Med
, vol.169
, pp. 441-447
-
-
Barst, R.J.1
Langleben, D.2
Frost, A.3
Horn, E.M.4
Oudiz, R.5
Shapiro, S.6
-
10
-
-
48849094089
-
Endothelin: 20 years from discovery to therapy
-
Barton M, Yanagisawa M, (2008). Endothelin: 20 years from discovery to therapy. Can J Physiol Pharmacol 86: 485-498.
-
(2008)
Can J Physiol Pharmacol
, vol.86
, pp. 485-498
-
-
Barton, M.1
Yanagisawa, M.2
-
11
-
-
0028609612
-
Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons
-
Baynash AG, Hosoda K, Giaid A, Richardson JA, Emoto N, Hammer RE, et al. (1994). Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 79: 1277-1285.
-
(1994)
Cell
, vol.79
, pp. 1277-1285
-
-
Baynash, A.G.1
Hosoda, K.2
Giaid, A.3
Richardson, J.A.4
Emoto, N.5
Hammer, R.E.6
-
12
-
-
84866307803
-
The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist
-
Bolli MH, Boss C, Binkert C, Buchmann S, Bur D, Hess P, et al. (2012). The discovery of N-[5-(4-bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N-p ropylsulfamide (Macitentan), an orally active, potent dual endothelin receptor antagonist. J Med Chem 55: 7849-7861.
-
(2012)
J Med Chem
, vol.55
, pp. 7849-7861
-
-
Bolli, M.H.1
Boss, C.2
Binkert, C.3
Buchmann, S.4
Bur, D.5
Hess, P.6
-
13
-
-
84874564133
-
Endothelin-2-mediated protection of mutant photoreceptors in inherited photoreceptor degeneration
-
Bramall AN, Szego MJ, Pacione LR, Chang I, Diez E, D'Orleans-Juste P, et al. (2013). Endothelin-2-mediated protection of mutant photoreceptors in inherited photoreceptor degeneration. PLoS ONE 8: e58023.
-
(2013)
PLoS ONE
, vol.8
, pp. e58023
-
-
Bramall, A.N.1
Szego, M.J.2
Pacione, L.R.3
Chang, I.4
Diez, E.5
D'Orleans-Juste, P.6
-
14
-
-
84867652327
-
Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage
-
Braunger BM, Ohlmann A, Koch M, Tanimoto N, Volz C, Yang Y, et al. (2013). Constitutive overexpression of Norrin activates Wnt/beta-catenin and endothelin-2 signaling to protect photoreceptors from light damage. Neurobiol Dis 50: 1-12.
-
(2013)
Neurobiol Dis
, vol.50
, pp. 1-12
-
-
Braunger, B.M.1
Ohlmann, A.2
Koch, M.3
Tanimoto, N.4
Volz, C.5
Yang, Y.6
-
15
-
-
0034625454
-
Regulation and intracellular trafficking pathways of the endothelin receptors
-
Bremnes T, Paasche JD, Mehlum A, Sandberg C, Bremnes B, Attramadal H, (2000). Regulation and intracellular trafficking pathways of the endothelin receptors. J Biol Chem 275: 17596-17604.
-
(2000)
J Biol Chem
, vol.275
, pp. 17596-17604
-
-
Bremnes, T.1
Paasche, J.D.2
Mehlum, A.3
Sandberg, C.4
Bremnes, B.5
Attramadal, H.6
-
16
-
-
84895512179
-
Endothelin receptor type B agonist, IRL-1620, prevents beta amyloid (Abeta) induced oxidative stress and cognitive impairment in normal and diabetic rats
-
Briyal S, Shepard C, Gulati A, (2014). Endothelin receptor type B agonist, IRL-1620, prevents beta amyloid (Abeta) induced oxidative stress and cognitive impairment in normal and diabetic rats. Pharmacol Biochem Behav 120C: 65-72.
-
(2014)
Pharmacol Biochem Behav
, vol.120 C
, pp. 65-72
-
-
Briyal, S.1
Shepard, C.2
Gulati, A.3
-
17
-
-
84857627857
-
Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist
-
Bruderer S, Aanismaa P, Homery MC, Hausler S, Landskroner K, Sidharta PN, et al. (2012a). Effect of cyclosporine and rifampin on the pharmacokinetics of macitentan, a tissue-targeting dual endothelin receptor antagonist. AAPS J 14: 68-78.
-
(2012)
AAPS J
, vol.14
, pp. 68-78
-
-
Bruderer, S.1
Aanismaa, P.2
Homery, M.C.3
Hausler, S.4
Landskroner, K.5
Sidharta, P.N.6
-
18
-
-
84865010567
-
Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans
-
Bruderer S, Hopfgartner G, Seiberling M, Wank J, Sidharta PN, Treiber A, et al. (2012b). Absorption, distribution, metabolism, and excretion of macitentan, a dual endothelin receptor antagonist, in humans. Xenobiotica 42: 901-910.
-
(2012)
Xenobiotica
, vol.42
, pp. 901-910
-
-
Bruderer, S.1
Hopfgartner, G.2
Seiberling, M.3
Wank, J.4
Sidharta, P.N.5
Treiber, A.6
-
19
-
-
84879477934
-
Pharmacokinetics of macitentan in Caucasian and Japanese subjects: The influence of ethnicity and sex
-
Bruderer S, Marjason J, Sidharta PN, Dingemanse J, (2013). Pharmacokinetics of macitentan in Caucasian and Japanese subjects: the influence of ethnicity and sex. Pharmacology 91: 331-338.
-
(2013)
Pharmacology
, vol.91
, pp. 331-338
-
-
Bruderer, S.1
Marjason, J.2
Sidharta, P.N.3
Dingemanse, J.4
-
20
-
-
84896867400
-
Beta-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury
-
Buelli S, Rosano L, Gagliardini E, Corna D, Longaretti L, Pezzotta A, et al. (2014). Beta-arrestin-1 drives endothelin-1-mediated podocyte activation and sustains renal injury. J Am Soc Nephrol 25: 523-533.
-
(2014)
J Am Soc Nephrol
, vol.25
, pp. 523-533
-
-
Buelli, S.1
Rosano, L.2
Gagliardini, E.3
Corna, D.4
Longaretti, L.5
Pezzotta, A.6
-
21
-
-
0025661934
-
Lack of biological activity of preproendothelin [110-130] in several endothelin assays
-
Cade C, Lumma WC Jr, Mohan R, Rubanyi GM, Parker-Botelho LH, (1990). Lack of biological activity of preproendothelin [110-130] in several endothelin assays. Life Sci 47: 2097-2103.
-
(1990)
Life Sci
, vol.47
, pp. 2097-2103
-
-
Cade, C.1
Lumma, W.C.2
Mohan, R.3
Rubanyi, G.M.4
Parker-Botelho, L.H.5
-
22
-
-
84878584063
-
Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice
-
Chang I, Bramall AN, Baynash AG, Rattner A, Rakheja D, Post M, et al. (2013). Endothelin-2 deficiency causes growth retardation, hypothermia, and emphysema in mice. J Clin Invest 123: 2643-2653.
-
(2013)
J Clin Invest
, vol.123
, pp. 2643-2653
-
-
Chang, I.1
Bramall, A.N.2
Baynash, A.G.3
Rattner, A.4
Rakheja, D.5
Post, M.6
-
23
-
-
84894528689
-
Beta-arrestin 1 is required for endothelin-1-induced NF-kappaB activation in ovarian cancer cells
-
Cianfrocca R, Tocci P, Semprucci E, Spinella F, Di Castro V, Bagnato A, et al. (2014). Beta-arrestin 1 is required for endothelin-1-induced NF-kappaB activation in ovarian cancer cells. Life Sci. doi: 10.1016/j.lfs.2014.01.078
-
(2014)
Life Sci
-
-
Cianfrocca, R.1
Tocci, P.2
Semprucci, E.3
Spinella, F.4
Di Castro, V.5
Bagnato, A.6
-
24
-
-
0031916129
-
Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice
-
Clouthier DE, Hosoda K, Richardson JA, Williams SC, Yanagisawa H, Kuwaki T, et al. (1998). Cranial and cardiac neural crest defects in endothelin-A receptor-deficient mice. Development 125: 813-824.
-
(1998)
Development
, vol.125
, pp. 813-824
-
-
Clouthier, D.E.1
Hosoda, K.2
Richardson, J.A.3
Williams, S.C.4
Yanagisawa, H.5
Kuwaki, T.6
-
25
-
-
0028824396
-
Are there different ETB receptors mediating constriction and relaxation?
-
Clozel M, Gray GA, (1995). Are there different ETB receptors mediating constriction and relaxation? J Cardiovasc Pharmacol 26 (Suppl. 3): S262-S264.
-
(1995)
J Cardiovasc Pharmacol
, vol.26
, pp. S262-S264
-
-
Clozel, M.1
Gray, G.A.2
-
26
-
-
84886796389
-
Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries
-
Compeer MG, Janssen GM, De Mey JG, (2013). Endothelin-1 and endothelin-2 initiate and maintain contractile responses by different mechanisms in rat mesenteric and cerebral arteries. Br J Pharmacol 170: 1199-1209.
-
(2013)
Br J Pharmacol
, vol.170
, pp. 1199-1209
-
-
Compeer, M.G.1
Janssen, G.M.2
De Mey, J.G.3
-
27
-
-
0036266042
-
International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature
-
Davenport AP, (2002). International Union of Pharmacology. XXIX. Update on endothelin receptor nomenclature. Pharmacol Rev 54: 219-226.
-
(2002)
Pharmacol Rev
, vol.54
, pp. 219-226
-
-
Davenport, A.P.1
-
29
-
-
0025181868
-
A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: Comparison of levels in patients with essential hypertension and normotensive control subjects
-
Davenport AP, Ashby MJ, Easton P, Ella S, Bedford J, Dickerson C, et al. (1990). A sensitive radioimmunoassay measuring endothelin-like immunoreactivity in human plasma: comparison of levels in patients with essential hypertension and normotensive control subjects. Clin Sci (Lond) 78: 261-264.
-
(1990)
Clin Sci (Lond)
, vol.78
, pp. 261-264
-
-
Davenport, A.P.1
Ashby, M.J.2
Easton, P.3
Ella, S.4
Bedford, J.5
Dickerson, C.6
-
30
-
-
84878371294
-
International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: Recommendations for new pairings with cognate ligands
-
Davenport AP, Alexander SP, Sharman JL, Pawson AJ, Benson HE, Monaghan AE, et al. (2013). International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands. Pharmacol Rev 65: 967-986.
-
(2013)
Pharmacol Rev
, vol.65
, pp. 967-986
-
-
Davenport, A.P.1
Alexander, S.P.2
Sharman, J.L.3
Pawson, A.J.4
Benson, H.E.5
Monaghan, A.E.6
-
31
-
-
0028171845
-
Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme
-
De Lombaert S, Ghai RD, Jeng AY, Trapani AJ, Webb RL, (1994). Pharmacological profile of a non-peptidic dual inhibitor of neutral endopeptidase 24.11 and endothelin-converting enzyme. Biochem Biophys Res Commun 204: 407-412.
-
(1994)
Biochem Biophys Res Commun
, vol.204
, pp. 407-412
-
-
De Lombaert, S.1
Ghai, R.D.2
Jeng, A.Y.3
Trapani, A.J.4
Webb, R.L.5
-
32
-
-
84855498432
-
Endothelin antagonism in patients with nondiabetic chronic kidney disease
-
Dhaun N, Goddard J, Webb DJ, (2011). Endothelin antagonism in patients with nondiabetic chronic kidney disease. Contrib Nephrol 172: 243-254.
-
(2011)
Contrib Nephrol
, vol.172
, pp. 243-254
-
-
Dhaun, N.1
Goddard, J.2
Webb, D.J.3
-
33
-
-
84866979287
-
Endothelin-1 and the kidney-beyond BP
-
Dhaun N, Webb DJ, Kluth DC, (2012). Endothelin-1 and the kidney-beyond BP. Br J Pharmacol 167: 720-731.
-
(2012)
Br J Pharmacol
, vol.167
, pp. 720-731
-
-
Dhaun, N.1
Webb, D.J.2
Kluth, D.C.3
-
34
-
-
3142576948
-
Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure
-
Dickstein K, De Voogd HJ, Miric MP, Willenbrock R, Mitrovic V, Pacher R, et al. (2004). Effect of single doses of SLV306, an inhibitor of both neutral endopeptidase and endothelin-converting enzyme, on pulmonary pressures in congestive heart failure. Am J Cardiol 94: 237-239.
-
(2004)
Am J Cardiol
, vol.94
, pp. 237-239
-
-
Dickstein, K.1
De Voogd, H.J.2
Miric, M.P.3
Willenbrock, R.4
Mitrovic, V.5
Pacher, R.6
-
35
-
-
0034809524
-
Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1
-
Docherty CC, Kalmar-Nagy J, Engelen M, Koenen SV, Nijland M, Kuc RE, et al. (2001). Effect of in vivo fetal infusion of dexamethasone at 0.75 GA on fetal ovine resistance artery responses to ET-1. Am J Physiol Regul Integr Comp Physiol 281: R261-R268.
-
(2001)
Am J Physiol Regul Integr Comp Physiol
, vol.281
, pp. R261-R268
-
-
Docherty, C.C.1
Kalmar-Nagy, J.2
Engelen, M.3
Koenen, S.V.4
Nijland, M.5
Kuc, R.E.6
-
36
-
-
84871383146
-
Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan
-
Don GW, Joseph F, Celermajer DS, Corte TJ, (2012). Ironic case of hepatic dysfunction following the global withdrawal of sitaxentan. Intern Med J 42: 1351-1354.
-
(2012)
Intern Med J
, vol.42
, pp. 1351-1354
-
-
Don, G.W.1
Joseph, F.2
Celermajer, D.S.3
Corte, T.J.4
-
37
-
-
50949114137
-
Endothelin-1 (1-31): From chymase-dependent synthesis to cardiovascular pathologies
-
D'Orleans-Juste P, Houde M, Rae GA, Bkaily G, Carrier E, Simard E, (2008). Endothelin-1 (1-31): from chymase-dependent synthesis to cardiovascular pathologies. Vascul Pharmacol 49: 51-62.
-
(2008)
Vascul Pharmacol
, vol.49
, pp. 51-62
-
-
D'Orleans-Juste, P.1
Houde, M.2
Rae, G.A.3
Bkaily, G.4
Carrier, E.5
Simard, E.6
-
38
-
-
84871585276
-
The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth
-
Drawnel FM, Archer CR, Roderick HL, (2013). The role of the paracrine/autocrine mediator endothelin-1 in regulation of cardiac contractility and growth. Br J Pharmacol 168: 296-317.
-
(2013)
Br J Pharmacol
, vol.168
, pp. 296-317
-
-
Drawnel, F.M.1
Archer, C.R.2
Roderick, H.L.3
-
39
-
-
0035816707
-
Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme
-
Eckman EA, Reed DK, Eckman CB, (2001). Degradation of the Alzheimer's amyloid beta peptide by endothelin-converting enzyme. J Biol Chem 276: 24540-24548.
-
(2001)
J Biol Chem
, vol.276
, pp. 24540-24548
-
-
Eckman, E.A.1
Reed, D.K.2
Eckman, C.B.3
-
40
-
-
0037462769
-
Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme
-
Eckman EA, Watson M, Marlow L, Sambamurti K, Eckman CB, (2003). Alzheimer's disease beta-amyloid peptide is increased in mice deficient in endothelin-converting enzyme. J Biol Chem 278: 2081-2084.
-
(2003)
J Biol Chem
, vol.278
, pp. 2081-2084
-
-
Eckman, E.A.1
Watson, M.2
Marlow, L.3
Sambamurti, K.4
Eckman, C.B.5
-
41
-
-
33750047859
-
Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme
-
Eckman EA, Adams SK, Troendle FJ, Stodola BA, Kahn MA, Fauq AH, et al. (2006). Regulation of steady-state beta-amyloid levels in the brain by neprilysin and endothelin-converting enzyme but not angiotensin-converting enzyme. J Biol Chem 281: 30471-30478.
-
(2006)
J Biol Chem
, vol.281
, pp. 30471-30478
-
-
Eckman, E.A.1
Adams, S.K.2
Troendle, F.J.3
Stodola, B.A.4
Kahn, M.A.5
Fauq, A.H.6
-
42
-
-
0029017876
-
Endothelin-converting enzyme-2 is a membrane-bound,phosphoramidon-sensitive metalloprotease with acidic pH optimum
-
Emoto N, Yanagisawa M, (1995). Endothelin-converting enzyme-2 is a membrane-bound,phosphoramidon-sensitive metalloprotease with acidic pH optimum. J Biol Chem 270: 15262-15268.
-
(1995)
J Biol Chem
, vol.270
, pp. 15262-15268
-
-
Emoto, N.1
Yanagisawa, M.2
-
43
-
-
21744460362
-
Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo
-
Fecteau MH, Honore JC, Plante M, Labonte J, Rae GA, D'Orleans-Juste P, (2005). Endothelin-1 (1-31) is an intermediate in the production of endothelin-1 after big endothelin-1 administration in vivo. Hypertension 46: 87-92.
-
(2005)
Hypertension
, vol.46
, pp. 87-92
-
-
Fecteau, M.H.1
Honore, J.C.2
Plante, M.3
Labonte, J.4
Rae, G.A.5
D'Orleans-Juste, P.6
-
44
-
-
0031799003
-
Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology
-
Flynn MA, Haleen SJ, Welch KM, Cheng XM, Reynolds EE, (1998). Endothelin B receptors on human endothelial and smooth-muscle cells show equivalent binding pharmacology. J Cardiovasc Pharmacol 32: 106-116.
-
(1998)
J Cardiovasc Pharmacol
, vol.32
, pp. 106-116
-
-
Flynn, M.A.1
Haleen, S.J.2
Welch, K.M.3
Cheng, X.M.4
Reynolds, E.E.5
-
45
-
-
22944457221
-
International Union of Pharmacology. XLVI. G protein-coupled receptor list
-
Foord SM, Bonner TI, Neubig RR, Rosser EM, Pin JP, Davenport AP, et al. (2005). International Union of Pharmacology. XLVI. G protein-coupled receptor list. Pharmacol Rev 57: 279-288.
-
(2005)
Pharmacol Rev
, vol.57
, pp. 279-288
-
-
Foord, S.M.1
Bonner, T.I.2
Neubig, R.R.3
Rosser, E.M.4
Pin, J.P.5
Davenport, A.P.6
-
46
-
-
84867562420
-
Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells
-
Gatfield J, Mueller Grandjean C, Sasse T, Clozel M, Nayler O, (2012). Slow receptor dissociation kinetics differentiate macitentan from other endothelin receptor antagonists in pulmonary arterial smooth muscle cells. PLoS ONE 7: e47662.
-
(2012)
PLoS ONE
, vol.7
, pp. e47662
-
-
Gatfield, J.1
Mueller Grandjean, C.2
Sasse, T.3
Clozel, M.4
Nayler, O.5
-
47
-
-
0025975489
-
Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain
-
Giaid A, Gibson SJ, Herrero MT, Gentleman S, Legon S, Yanagisawa M, et al. (1991). Topographical localisation of endothelin mRNA and peptide immunoreactivity in neurones of the human brain. Histochemistry 95: 303-314.
-
(1991)
Histochemistry
, vol.95
, pp. 303-314
-
-
Giaid, A.1
Gibson, S.J.2
Herrero, M.T.3
Gentleman, S.4
Legon, S.5
Yanagisawa, M.6
-
48
-
-
11144305358
-
Endothelin-1-induced vasodilatation in rat Breast tumor is mediated through endothelin-B receptors
-
Gulati A, Rai A, (2004). Endothelin-1-induced vasodilatation in rat Breast tumor is mediated through endothelin-B receptors. J Cardiovasc Pharmacol 44: S483-S486.
-
(2004)
J Cardiovasc Pharmacol
, vol.44
, pp. S483-S486
-
-
Gulati, A.1
Rai, A.2
-
49
-
-
84858729714
-
IRL-1620, an endothelin-B receptor agonist, enhanced radiation induced reduction in tumor volume in Dalton's Lymphoma Ascites tumor model
-
Gulati A, Sunila ES, Kuttan G, (2012). IRL-1620, an endothelin-B receptor agonist, enhanced radiation induced reduction in tumor volume in Dalton's Lymphoma Ascites tumor model. Arzneimittelforschung 62: 14-17.
-
(2012)
Arzneimittelforschung
, vol.62
, pp. 14-17
-
-
Gulati, A.1
Sunila, E.S.2
Kuttan, G.3
-
50
-
-
0032910612
-
Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure
-
Hand MF, Haynes WG, Webb DJ, (1999). Reduced endogenous endothelin-1-mediated vascular tone in chronic renal failure. Kidney Int 55: 613-620.
-
(1999)
Kidney Int
, vol.55
, pp. 613-620
-
-
Hand, M.F.1
Haynes, W.G.2
Webb, D.J.3
-
51
-
-
0028827686
-
Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas
-
Harland SP, Kuc RE, Pickard JD, Davenport AP, (1995). Characterization of endothelin receptors in human brain cortex, gliomas, and meningiomas. J Cardiovasc Pharmacol 26 (Suppl. 3): S408-S411.
-
(1995)
J Cardiovasc Pharmacol
, vol.26
, pp. S408-S411
-
-
Harland, S.P.1
Kuc, R.E.2
Pickard, J.D.3
Davenport, A.P.4
-
52
-
-
0031752311
-
Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707
-
Harland SP, Kuc RE, Pickard JD, Davenport AP, (1998). Expression of endothelin(A) receptors in human gliomas and meningiomas, with high affinity for the selective antagonist PD156707. Neurosurgery 43: 890-898.
-
(1998)
Neurosurgery
, vol.43
, pp. 890-898
-
-
Harland, S.P.1
Kuc, R.E.2
Pickard, J.D.3
Davenport, A.P.4
-
53
-
-
0027983753
-
Contribution of endogenous generation of endothelin-1 to basal vascular tone
-
Haynes WG, Webb DJ, (1994). Contribution of endogenous generation of endothelin-1 to basal vascular tone. Lancet 344: 852-854.
-
(1994)
Lancet
, vol.344
, pp. 852-854
-
-
Haynes, W.G.1
Webb, D.J.2
-
54
-
-
79960286159
-
Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure
-
Hocher B, Heiden S, von Websky K, Rahnenfuhre J, Kalk P, Pfab T, (2011). Dual endothelin-converting enzyme/neutral endopeptidase blockade in rats with D-galactosamine-induced liver failure. Eur J Med Res 16: 275-279.
-
(2011)
Eur J Med Res
, vol.16
, pp. 275-279
-
-
Hocher, B.1
Heiden, S.2
Von Websky, K.3
Rahnenfuhre, J.4
Kalk, P.5
Pfab, T.6
-
55
-
-
0028639196
-
Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice
-
Hosoda K, Hammer RE, Richardson JA, Baynash AG, Cheung JC, Giaid A, et al. (1994). Targeted and natural (piebald-lethal) mutations of endothelin-B receptor gene produce megacolon associated with spotted coat color in mice. Cell 79: 1267-1276.
-
(1994)
Cell
, vol.79
, pp. 1267-1276
-
-
Hosoda, K.1
Hammer, R.E.2
Richardson, J.A.3
Baynash, A.G.4
Cheung, J.C.5
Giaid, A.6
-
56
-
-
0026480318
-
Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue
-
Howard PG, Plumpton C, Davenport AP, (1992). Anatomical localization and pharmacological activity of mature endothelins and their precursors in human vascular tissue. J Hypertens 10: 1379-1386.
-
(1992)
J Hypertens
, vol.10
, pp. 1379-1386
-
-
Howard, P.G.1
Plumpton, C.2
Davenport, A.P.3
-
57
-
-
84871751539
-
Nitric oxide and the A and B of endothelin of sodium homeostasis
-
Hyndman KA, Pollock JS, (2013). Nitric oxide and the A and B of endothelin of sodium homeostasis. Curr Opin Nephrol Hypertens 22: 26-31.
-
(2013)
Curr Opin Nephrol Hypertens
, vol.22
, pp. 26-31
-
-
Hyndman, K.A.1
Pollock, J.S.2
-
58
-
-
57349133022
-
Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist
-
Iglarz M, Binkert C, Morrison K, Fischli W, Gatfield J, Treiber A, et al. (2008). Pharmacology of macitentan, an orally active tissue-targeting dual endothelin receptor antagonist. J Pharmacol Exp Ther 327: 736-745.
-
(2008)
J Pharmacol Exp Ther
, vol.327
, pp. 736-745
-
-
Iglarz, M.1
Binkert, C.2
Morrison, K.3
Fischli, W.4
Gatfield, J.5
Treiber, A.6
-
60
-
-
0036289477
-
Molecular isolation and characterization of novel four subisoforms of ECE-2
-
Ikeda S, Emto N, Alimsardjono H, Yokoyama M, Matsuo M, (2002). Molecular isolation and characterization of novel four subisoforms of ECE-2. Biochem Biophys Res Commun 293: 421-426.
-
(2002)
Biochem Biophys Res Commun
, vol.293
, pp. 421-426
-
-
Ikeda, S.1
Emto, N.2
Alimsardjono, H.3
Yokoyama, M.4
Matsuo, M.5
-
61
-
-
0013543367
-
The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
-
Inoue A, Yanagisawa M, Kimura S, Kasuya Y, Miyauchi T, Goto K, et al. (1989). The human endothelin family: three structurally and pharmacologically distinct isopeptides predicted by three separate genes. Proc Natl Acad Sci U S A 86: 2863-2867.
-
(1989)
Proc Natl Acad Sci U S A
, vol.86
, pp. 2863-2867
-
-
Inoue, A.1
Yanagisawa, M.2
Kimura, S.3
Kasuya, Y.4
Miyauchi, T.5
Goto, K.6
-
62
-
-
0028237258
-
Biochemical and pharmacological profile of a potent and selective endothelinB-receptor antagonist, BQ-788
-
Ishikawa K, Ihara M, Noguchi K, Mase T, Mino N, Saeki T, et al. (1994). Biochemical and pharmacological profile of a potent and selective endothelinB-receptor antagonist, BQ-788. Proc Natl Acad Sci U S A 91: 4892-4896.
-
(1994)
Proc Natl Acad Sci U S A
, vol.91
, pp. 4892-4896
-
-
Ishikawa, K.1
Ihara, M.2
Noguchi, K.3
Mase, T.4
Mino, N.5
Saeki, T.6
-
63
-
-
84887057897
-
Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-beta peptide(1-40) in mouse brain
-
Ito S, Matsumiya K, Ohtsuki S, Kamiie J, Terasaki T, (2013). Contributions of degradation and brain-to-blood elimination across the blood-brain barrier to cerebral clearance of human amyloid-beta peptide(1-40) in mouse brain. J Cereb Blood Flow Metab 33: 1770-1777.
-
(2013)
J Cereb Blood Flow Metab
, vol.33
, pp. 1770-1777
-
-
Ito, S.1
Matsumiya, K.2
Ohtsuki, S.3
Kamiie, J.4
Terasaki, T.5
-
64
-
-
0036099334
-
Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications
-
Jeng AY, Mulder P, Kwan AL, Battistini B, (2002). Nonpeptidic endothelin-converting enzyme inhibitors and their potential therapeutic applications. Can J Physiol Pharmacol 80: 440-449.
-
(2002)
Can J Physiol Pharmacol
, vol.80
, pp. 440-449
-
-
Jeng, A.Y.1
Mulder, P.2
Kwan, A.L.3
Battistini, B.4
-
65
-
-
77249163226
-
Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver
-
Johnström P, Fryer TD, Richards HK, Maguire JJ, Clark JC, Pickard JD, et al. (2010). Positron emission tomography of [18F]-big endothelin-1 reveals renal excretion but tissue-specific conversion to [18F]-endothelin-1 in lung and liver. Br J Pharmacol 159: 812-819.
-
(2010)
Br J Pharmacol
, vol.159
, pp. 812-819
-
-
Johnström, P.1
Fryer, T.D.2
Richards, H.K.3
Maguire, J.J.4
Clark, J.C.5
Pickard, J.D.6
-
66
-
-
79953200072
-
Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner
-
Kalk P, Sharkovska Y, Kashina E, von Websky K, Relle K, Pfab T, et al. (2011). Endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner. Hypertension 57: 755-763.
-
(2011)
Hypertension
, vol.57
, pp. 755-763
-
-
Kalk, P.1
Sharkovska, Y.2
Kashina, E.3
Von Websky, K.4
Relle, K.5
Pfab, T.6
-
67
-
-
0030044458
-
Localization of endothelin peptides in human kidney
-
Karet FE, Davenport AP, (1996). Localization of endothelin peptides in human kidney. Kidney Int 49: 382-387.
-
(1996)
Kidney Int
, vol.49
, pp. 382-387
-
-
Karet, F.E.1
Davenport, A.P.2
-
68
-
-
79952278486
-
Endothelial cell-specific ETB receptor knockout: Autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1
-
Kelland NF, Kuc RE, McLean DL, Azfer A, Bagnall AJ, Gray GA, et al. (2010). Endothelial cell-specific ETB receptor knockout: autoradiographic and histological characterisation and crucial role in the clearance of endothelin-1. Can J Physiol Pharmacol 88: 644-651.
-
(2010)
Can J Physiol Pharmacol
, vol.88
, pp. 644-651
-
-
Kelland, N.F.1
Kuc, R.E.2
McLean, D.L.3
Azfer, A.4
Bagnall, A.J.5
Gray, G.A.6
-
69
-
-
33744942636
-
Clinical trials of endothelin antagonists in heart failure: A question of dose?
-
Kelland NF, Webb DJ, (2006). Clinical trials of endothelin antagonists in heart failure: a question of dose? Exp Biol Med (Maywood) 231: 696-699.
-
(2006)
Exp Biol Med (Maywood)
, vol.231
, pp. 696-699
-
-
Kelland, N.F.1
Webb, D.J.2
-
70
-
-
0025967080
-
Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor
-
Kiowski W, Luscher TF, Linder L, Buhler FR, (1991). Endothelin-1-induced vasoconstriction in humans. Reversal by calcium channel blockade but not by nitrovasodilators or endothelium-derived relaxing factor. Circulation 83: 469-475.
-
(1991)
Circulation
, vol.83
, pp. 469-475
-
-
Kiowski, W.1
Luscher, T.F.2
Linder, L.3
Buhler, F.R.4
-
71
-
-
40949132561
-
The endothelin system as a therapeutic target in cardiovascular disease: Great expectations or bleak house?
-
Kirkby NS, Hadoke PW, Bagnall AJ, Webb DJ, (2008). The endothelin system as a therapeutic target in cardiovascular disease: great expectations or bleak house? J Pharmacol 153: 1105-1119.
-
(2008)
J Pharmacol
, vol.153
, pp. 1105-1119
-
-
Kirkby, N.S.1
Hadoke, P.W.2
Bagnall, A.J.3
Webb, D.J.4
-
72
-
-
33645515497
-
Endothelin-2 in ovarian follicle rupture
-
Ko C, Gieske MC, Al-Alem L, Hahn Y, Su W, Gong MC, et al. (2006). Endothelin-2 in ovarian follicle rupture. Endocrinology 147: 1770-1779.
-
(2006)
Endocrinology
, vol.147
, pp. 1770-1779
-
-
Ko, C.1
Gieske, M.C.2
Al-Alem, L.3
Hahn, Y.4
Su, W.5
Gong, M.C.6
-
73
-
-
84867580770
-
Why two endothelins and two receptors for ovulation and luteal regulation?
-
Ko C, Meidan R, Bridges PJ, (2012). Why two endothelins and two receptors for ovulation and luteal regulation? Life Sci 91: 501-506.
-
(2012)
Life Sci
, vol.91
, pp. 501-506
-
-
Ko, C.1
Meidan, R.2
Bridges, P.J.3
-
74
-
-
84861886151
-
Physiology of endothelin and the kidney
-
Kohan DE, Inscho EW, Wesson D, Pollock DM, (2011a). Physiology of endothelin and the kidney. Compr Physiol 1: 883-919.
-
(2011)
Compr Physiol
, vol.1
, pp. 883-919
-
-
Kohan, D.E.1
Inscho, E.W.2
Wesson, D.3
Pollock, D.M.4
-
75
-
-
78751672175
-
Regulation of blood pressure and salt homeostasis by endothelin
-
Kohan DE, Rossi NF, Inscho EW, Pollock DM, (2011b). Regulation of blood pressure and salt homeostasis by endothelin. Physiol Rev 91: 1-77.
-
(2011)
Physiol Rev
, vol.91
, pp. 1-77
-
-
Kohan, D.E.1
Rossi, N.F.2
Inscho, E.W.3
Pollock, D.M.4
-
76
-
-
84867578602
-
Clinical trials with endothelin receptor antagonists: What went wrong and where can we improve?
-
Kohan DE, Cleland JG, Rubin LJ, Theodorescu D, Barton M, (2012). Clinical trials with endothelin receptor antagonists: what went wrong and where can we improve? Life Sci 91: 528-539.
-
(2012)
Life Sci
, vol.91
, pp. 528-539
-
-
Kohan, D.E.1
Cleland, J.G.2
Rubin, L.J.3
Theodorescu, D.4
Barton, M.5
-
77
-
-
84990943531
-
Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension
-
Kuc RE, Carlebur M, Maguire JJ, Yang P, Long L, Toshner M, et al. (2014). Modulation of endothelin receptors in the failing right ventricle of the heart and vasculature of the lung in human pulmonary arterial hypertension. Life Sci. doi: 10.1016/j.lfs.2014.02.020
-
(2014)
Life Sci
-
-
Kuc, R.E.1
Carlebur, M.2
Maguire, J.J.3
Yang, P.4
Long, L.5
Toshner, M.6
-
78
-
-
0028360062
-
Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1
-
Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, et al. (1994). Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 368: 703-710.
-
(1994)
Nature
, vol.368
, pp. 703-710
-
-
Kurihara, Y.1
Kurihara, H.2
Suzuki, H.3
Kodama, T.4
Maemura, K.5
Nagai, R.6
-
79
-
-
0041858484
-
Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries
-
Kutzler MA, Molnar J, Schlafer DH, Kuc RE, Davenport AP, Nathanielsz PW, (2003). Maternal dexamethasone increases endothelin-1 sensitivity and endothelin a receptor expression in ovine foetal placental arteries. Placenta 24: 392-402.
-
(2003)
Placenta
, vol.24
, pp. 392-402
-
-
Kutzler, M.A.1
Molnar, J.2
Schlafer, D.H.3
Kuc, R.E.4
Davenport, A.P.5
Nathanielsz, P.W.6
-
80
-
-
0033566651
-
Proteolytic processing of big endothelin-3 by the kell blood group protein
-
Lee S, Lin M, Mele A, Cao Y, Farmar J, Russo D, et al. (1999). Proteolytic processing of big endothelin-3 by the kell blood group protein. Blood 94: 1440-1450.
-
(1999)
Blood
, vol.94
, pp. 1440-1450
-
-
Lee, S.1
Lin, M.2
Mele, A.3
Cao, Y.4
Farmar, J.5
Russo, D.6
-
81
-
-
84918772685
-
IRL-1620 increases the efficacy of radiation treatment in mice bearing lymphoma cell induced tumors
-
Lenaz L, Gulati A, Sunila E, (2006). IRL-1620 increases the efficacy of radiation treatment in mice bearing lymphoma cell induced tumors. Blood 108: 269B.
-
(2006)
Blood
, vol.108
, pp. 269B
-
-
Lenaz, L.1
Gulati, A.2
Sunila, E.3
-
82
-
-
84882263300
-
Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats
-
Leonard MG, Gulati A, (2013). Endothelin B receptor agonist, IRL-1620, enhances angiogenesis and neurogenesis following cerebral ischemia in rats. Brain Res 1528: 28-41.
-
(2013)
Brain Res
, vol.1528
, pp. 28-41
-
-
Leonard, M.G.1
Gulati, A.2
-
83
-
-
80055056846
-
Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats
-
Leonard MG, Briyal S, Gulati A, (2011). Endothelin B receptor agonist, IRL-1620, reduces neurological damage following permanent middle cerebral artery occlusion in rats. Brain Res 1420: 48-58.
-
(2011)
Brain Res
, vol.1420
, pp. 48-58
-
-
Leonard, M.G.1
Briyal, S.2
Gulati, A.3
-
84
-
-
84862017602
-
Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats
-
Leonard MG, Briyal S, Gulati A, (2012). Endothelin B receptor agonist, IRL-1620, provides long-term neuroprotection in cerebral ischemia in rats. Brain Res 1464: 14-23.
-
(2012)
Brain Res
, vol.1464
, pp. 14-23
-
-
Leonard, M.G.1
Briyal, S.2
Gulati, A.3
-
85
-
-
84871603109
-
Endothelin-2, the forgotten isoform: Emerging role in the cardiovascular system, ovarian development, immunology and cancer
-
Ling L, Maguire JJ, Davenport AP, (2013). Endothelin-2, the forgotten isoform: emerging role in the cardiovascular system, ovarian development, immunology and cancer. Br J Pharmacol 168: 283-295.
-
(2013)
Br J Pharmacol
, vol.168
, pp. 283-295
-
-
Ling, L.1
Maguire, J.J.2
Davenport, A.P.3
-
86
-
-
84875513420
-
Endothelin receptor antagonists for pulmonary arterial hypertension
-
CD004434.
-
Liu C, Chen J, Gao Y, Deng B, Liu K, (2013). Endothelin receptor antagonists for pulmonary arterial hypertension. Cochrane Database Syst Rev (2): CD004434.
-
(2013)
Cochrane Database Syst Rev
, Issue.2
-
-
Liu, C.1
Chen, J.2
Gao, Y.3
Deng, B.4
Liu, K.5
-
87
-
-
0035846451
-
Human endothelin converting enzyme-2 (ECE2): Characterization of mRNA species and chromosomal localization
-
Lorenzo MN, Khan RY, Wang Y, Tai SC, Chan GC, Cheung AH, et al. (2001). Human endothelin converting enzyme-2 (ECE2): characterization of mRNA species and chromosomal localization. Biochim Biophys Acta 1522: 46-52.
-
(2001)
Biochim Biophys Acta
, vol.1522
, pp. 46-52
-
-
Lorenzo, M.N.1
Khan, R.Y.2
Wang, Y.3
Tai, S.C.4
Chan, G.C.5
Cheung, A.H.6
-
88
-
-
0034123658
-
Endothelin receptor antagonism in patients with chronic heart failure
-
Love MP, Ferro CJ, Haynes WG, Plumpton C, Davenport AP, Webb DJ, et al. (2000). Endothelin receptor antagonism in patients with chronic heart failure. Cardiovasc Res 47: 166-172.
-
(2000)
Cardiovasc Res
, vol.47
, pp. 166-172
-
-
Love, M.P.1
Ferro, C.J.2
Haynes, W.G.3
Plumpton, C.4
Davenport, A.P.5
Webb, D.J.6
-
89
-
-
0029860376
-
Relaxation of human temporal artery by endothelin ETB receptors
-
Lucas GA, White LR, Juul R, Cappelen J, Aasly J, Edvinsson L, (1996). Relaxation of human temporal artery by endothelin ETB receptors. Peptides 17: 1139-1144.
-
(1996)
Peptides
, vol.17
, pp. 1139-1144
-
-
Lucas, G.A.1
White, L.R.2
Juul, R.3
Cappelen, J.4
Aasly, J.5
Edvinsson, L.6
-
90
-
-
84896703861
-
Minireview: More than just a hammer: Ligand 'bias' and pharmaceutical discovery
-
Luttrell LM, (2014). Minireview: more than just a hammer: ligand 'bias' and pharmaceutical discovery. Mol Endocrinol 28: 281-294.
-
(2014)
Mol Endocrinol
, vol.28
, pp. 281-294
-
-
Luttrell, L.M.1
-
91
-
-
0031671310
-
Increased response to big endothelin-1 in atherosclerotic human coronary artery: Functional evidence for up-regulation of endothelin-converting enzyme activity in disease
-
Maguire JJ, Davenport AP, (1998). Increased response to big endothelin-1 in atherosclerotic human coronary artery: functional evidence for up-regulation of endothelin-converting enzyme activity in disease. Br J Pharmacol 125: 238-240.
-
(1998)
Br J Pharmacol
, vol.125
, pp. 238-240
-
-
Maguire, J.J.1
Davenport, A.P.2
-
92
-
-
11144314960
-
Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels
-
Maguire JJ, Davenport AP, (2004). Alternative pathway to endothelin-converting enzyme for the synthesis of endothelin in human blood vessels. J Cardiovasc Pharmacol 44 (Suppl. 1): S27-S29.
-
(2004)
J Cardiovasc Pharmacol
, vol.44
, pp. S27-S29
-
-
Maguire, J.J.1
Davenport, A.P.2
-
93
-
-
0031451616
-
Endothelin converting enzyme (ECE). Activity in human vascular smooth muscle
-
Maguire JJ, Johnson CM, Mockridge JW, Davenport AP, (1997). Endothelin converting enzyme (ECE). Activity in human vascular smooth muscle. Br J Pharmacol 122: 1647-1654.
-
(1997)
Br J Pharmacol
, vol.122
, pp. 1647-1654
-
-
Maguire, J.J.1
Johnson, C.M.2
Mockridge, J.W.3
Davenport, A.P.4
-
94
-
-
0035200903
-
Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro
-
Maguire JJ, Kuc RE, Davenport AP, (2001). Vasoconstrictor activity of novel endothelin peptide, ET-1(1-31), in human mammary and coronary arteries in vitro. Br J Pharmacol 134: 1360-1366.
-
(2001)
Br J Pharmacol
, vol.134
, pp. 1360-1366
-
-
Maguire, J.J.1
Kuc, R.E.2
Davenport, A.P.3
-
95
-
-
84867581538
-
Comparison of human ETA and ETB receptor signalling via G-protein and beta-arrestin pathways
-
Maguire JJ, Kuc RE, Pell VR, Green A, Brown M, Kumar S, et al. (2012). Comparison of human ETA and ETB receptor signalling via G-protein and beta-arrestin pathways. Life Sci 91: 544-549.
-
(2012)
Life Sci
, vol.91
, pp. 544-549
-
-
Maguire, J.J.1
Kuc, R.E.2
Pell, V.R.3
Green, A.4
Brown, M.5
Kumar, S.6
-
96
-
-
0026757068
-
Localization of immunoreactive endothelin and proendothelin in the human lung
-
Marciniak SJ, Plumpton C, Barker PJ, Huskisson NS, Davenport AP, (1992). Localization of immunoreactive endothelin and proendothelin in the human lung. Pulm Pharmacol 5: 175-182.
-
(1992)
Pulm Pharmacol
, vol.5
, pp. 175-182
-
-
Marciniak, S.J.1
Plumpton, C.2
Barker, P.J.3
Huskisson, N.S.4
Davenport, A.P.5
-
97
-
-
0003315531
-
Pharmacology of the active metabolite of SLV 306 - A mixed inhibitor of NEP and ECE
-
Meil J, Wurl M, Thormahlen D, Rose H, (1998). Pharmacology of the active metabolite of SLV 306-a mixed inhibitor of NEP and ECE. Naunyn Schmiedebergs Arch Pharmacol 358 (Suppl. 1): R513.
-
(1998)
Naunyn Schmiedebergs Arch Pharmacol
, vol.358
, pp. R513
-
-
Meil, J.1
Wurl, M.2
Thormahlen, D.3
Rose, H.4
-
98
-
-
84878715626
-
GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin
-
Meyer RC, Giddens MM, Schaefer SA, Hall RA, (2013). GPR37 and GPR37L1 are receptors for the neuroprotective and glioprotective factors prosaptide and prosaposin. Proc Natl Acad Sci U S A 110: 9529-9534.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. 9529-9534
-
-
Meyer, R.C.1
Giddens, M.M.2
Schaefer, S.A.3
Hall, R.A.4
-
99
-
-
8244248458
-
Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse
-
Mizuguchi T, Nishiyama M, Moroi K, Tanaka H, Saito T, Masuda Y, et al. (1997). Analysis of two pharmacologically predicted endothelin B receptor subtypes by using the endothelin B receptor gene knockout mouse. Br J Pharmacol 120: 1427-1430.
-
(1997)
Br J Pharmacol
, vol.120
, pp. 1427-1430
-
-
Mizuguchi, T.1
Nishiyama, M.2
Moroi, K.3
Tanaka, H.4
Saito, T.5
Masuda, Y.6
-
100
-
-
0026615753
-
Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart
-
Molenaar P, Kuc RE, Davenport AP, (1992). Characterization of two new ETB selective radioligands, [125I]-BQ3020 and [125I]-[Ala1,3,11,15]ET-1 in human heart. Br J Pharmacol 107: 637-639.
-
(1992)
Br J Pharmacol
, vol.107
, pp. 637-639
-
-
Molenaar, P.1
Kuc, R.E.2
Davenport, A.P.3
-
101
-
-
0027538163
-
Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium
-
Molenaar P, O'Reilly G, Sharkey A, Kuc RE, Harding DP, Plumpton C, et al. (1993). Characterization and localization of endothelin receptor subtypes in the human atrioventricular conducting system and myocardium. Circ Res 72: 526-538.
-
(1993)
Circ Res
, vol.72
, pp. 526-538
-
-
Molenaar, P.1
O'Reilly, G.2
Sharkey, A.3
Kuc, R.E.4
Harding, D.P.5
Plumpton, C.6
-
102
-
-
0028931949
-
Regional and maturation-associated expression of endothelin 2 in rat gastrointestinal tract
-
de la Monte SM, Quertermous T, Hong CC, Bloch KD, (1995). Regional and maturation-associated expression of endothelin 2 in rat gastrointestinal tract. J Histochem Cytochem 43: 203-209.
-
(1995)
J Histochem Cytochem
, vol.43
, pp. 203-209
-
-
De La Monte, S.M.1
Quertermous, T.2
Hong, C.C.3
Bloch, K.D.4
-
103
-
-
0026690522
-
Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b
-
Morton AJ, Davenport AP, (1992). Cerebellar neurons and glia respond differentially to endothelins and sarafotoxin S6b. Brain Res 581: 299-306.
-
(1992)
Brain Res
, vol.581
, pp. 299-306
-
-
Morton, A.J.1
Davenport, A.P.2
-
104
-
-
0027958721
-
Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors
-
Nambi P, Pullen M, Spielman W, (1994). Species differences in the binding characteristics of [125I]IRL-1620, a potent agonist specific for endothelin-B receptors. J Pharmacol Exp Ther 268: 202-207.
-
(1994)
J Pharmacol Exp Ther
, vol.268
, pp. 202-207
-
-
Nambi, P.1
Pullen, M.2
Spielman, W.3
-
105
-
-
84867581900
-
Pharmacokinetic and pharmacodynamic properties of SOL1: A novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme
-
Nelissen J, Lemkens P, Sann H, Bindl M, Bassissi F, Jasserand D, et al. (2012). Pharmacokinetic and pharmacodynamic properties of SOL1: a novel dual inhibitor of neutral endopeptidase and endothelin converting enzyme. Life Sci 91: 587-592.
-
(2012)
Life Sci
, vol.91
, pp. 587-592
-
-
Nelissen, J.1
Lemkens, P.2
Sann, H.3
Bindl, M.4
Bassissi, F.5
Jasserand, D.6
-
106
-
-
84865428817
-
Pathophysiological roles of endothelin receptors in cardiovascular diseases
-
Ohkita M, Tawa M, Kitada K, Matsumura Y, (2012). Pathophysiological roles of endothelin receptors in cardiovascular diseases. J Pharmacol Sci 119: 302-313.
-
(2012)
J Pharmacol Sci
, vol.119
, pp. 302-313
-
-
Ohkita, M.1
Tawa, M.2
Kitada, K.3
Matsumura, Y.4
-
107
-
-
0027337782
-
Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution
-
O'Reilly G, Charnock-Jones DS, Morrison JJ, Cameron IT, Davenport AP, Smith SK, (1993). Alternatively spliced mRNAs for human endothelin-2 and their tissue distribution. Biochem Biophys Res Commun 193: 834-840.
-
(1993)
Biochem Biophys Res Commun
, vol.193
, pp. 834-840
-
-
O'Reilly, G.1
Charnock-Jones, D.S.2
Morrison, J.J.3
Cameron, I.T.4
Davenport, A.P.5
Smith, S.K.6
-
108
-
-
84874302223
-
Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway and autophagosomes
-
Pacheco-Quinto J, Eckman EA, (2013). Endothelin-converting enzymes degrade intracellular beta-amyloid produced within the endosomal/lysosomal pathway and autophagosomes. J Biol Chem 288: 5606-5615.
-
(2013)
J Biol Chem
, vol.288
, pp. 5606-5615
-
-
Pacheco-Quinto, J.1
Eckman, E.A.2
-
109
-
-
33751544162
-
A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice
-
Palanisamy GS, Cheon YP, Kim J, Kannan A, Li Q, Sato M, et al. (2006). A novel pathway involving progesterone receptor, endothelin-2, and endothelin receptor B controls ovulation in mice. Mol Endocrinol 20: 2784-2795.
-
(2006)
Mol Endocrinol
, vol.20
, pp. 2784-2795
-
-
Palanisamy, G.S.1
Cheon, Y.P.2
Kim, J.3
Kannan, A.4
Li, Q.5
Sato, M.6
-
110
-
-
62849094138
-
Endothelin receptor antagonists: Status and learning 20 years on
-
Palmer MJ, (2009). Endothelin receptor antagonists: status and learning 20 years on. Prog Med Chem 47: 203-237.
-
(2009)
Prog Med Chem
, vol.47
, pp. 203-237
-
-
Palmer, M.J.1
-
111
-
-
84882597884
-
Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: A randomised, crossover, double-blind, placebo-controlled trial
-
Parvanova A, van der Meer IM, Iliev I, Perna A, Gaspari F, Trevisan R, et al. (2013). Effect on blood pressure of combined inhibition of endothelin-converting enzyme and neutral endopeptidase with daglutril in patients with type 2 diabetes who have albuminuria: a randomised, crossover, double-blind, placebo-controlled trial. Lancet Diabetes Endocrinol 1: 19-27.
-
(2013)
Lancet Diabetes Endocrinol
, vol.1
, pp. 19-27
-
-
Parvanova, A.1
Van Der Meer, I.M.2
Iliev, I.3
Perna, A.4
Gaspari, F.5
Trevisan, R.6
-
112
-
-
84893041865
-
Macitentan: First global approval
-
Patel T, McKeage K, (2014). Macitentan: first global approval. Drugs 74: 127-133.
-
(2014)
Drugs
, vol.74
, pp. 127-133
-
-
Patel, T.1
McKeage, K.2
-
113
-
-
84891791940
-
The IUPHAR/BPS Guide to PHARMACOLOGY: An expert-driven knowledgebase of drug targets and their ligands
-
DATABASE ISSUE
-
Pawson AJ, Sharman JL, Benson HE, Faccenda E, Alexander SP, Buneman OP, et al. (2014). The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands. Nucleic Acids Res 42 (Database Issue): D1098-D1106.
-
(2014)
Nucleic Acids Res
, vol.42
, pp. D1098-D1106
-
-
Pawson, A.J.1
Sharman, J.L.2
Benson, H.E.3
Faccenda, E.4
Alexander, S.P.5
Buneman, O.P.6
-
114
-
-
84867582084
-
New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus
-
Pernow J, Shemyakin A, Böhm F, (2012). New perspectives on endothelin-1 in atherosclerosis and diabetes mellitus. Life Sci 91: 507-516.
-
(2012)
Life Sci
, vol.91
, pp. 507-516
-
-
Pernow, J.1
Shemyakin, A.2
Böhm, F.3
-
115
-
-
0028868580
-
Delineation of endothelin receptors in human left ventricular smooth-muscle cells
-
Peter MG, Davenport AP, (1995). Delineation of endothelin receptors in human left ventricular smooth-muscle cells. J Cardiovasc Pharmacol 26 (Suppl. 3): S355-S357.
-
(1995)
J Cardiovasc Pharmacol
, vol.26
, pp. S355-S357
-
-
Peter, M.G.1
Davenport, A.P.2
-
116
-
-
0030020431
-
Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart
-
Peter MG, Davenport AP, (1996). Characterization of the endothelin receptor selective agonist, BQ3020 and antagonists BQ123, FR139317, BQ788, 50235, Ro462005 and bosentan in the heart. Br J Pharmacol 117: 455-462.
-
(1996)
Br J Pharmacol
, vol.117
, pp. 455-462
-
-
Peter, M.G.1
Davenport, A.P.2
-
117
-
-
0032967302
-
Blockade and reversal of endothelin-induced constriction in pial arteries from human brain
-
Pierre LN, Davenport AP, (1999). Blockade and reversal of endothelin-induced constriction in pial arteries from human brain. Stroke 30: 638-643.
-
(1999)
Stroke
, vol.30
, pp. 638-643
-
-
Pierre, L.N.1
Davenport, A.P.2
-
118
-
-
0029813755
-
The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044
-
Plumpton C, Ferro CJ, Haynes WG, Webb DJ, Davenport AP, (1996a). The increase in human plasma immunoreactive endothelin but not big endothelin-1 or its C-terminal fragment induced by systemic administration of the endothelin antagonist TAK-044. Br J Pharmacol 119: 311-314.
-
(1996)
Br J Pharmacol
, vol.119
, pp. 311-314
-
-
Plumpton, C.1
Ferro, C.J.2
Haynes, W.G.3
Webb, D.J.4
Davenport, A.P.5
-
119
-
-
0030065517
-
Expression of endothelin peptides and mRNA in the human heart
-
Plumpton C, Ashby MJ, Kuc RE, O'Reilly G, Davenport AP, (1996b). Expression of endothelin peptides and mRNA in the human heart. Clin Sci (Lond) 90: 37-46.
-
(1996)
Clin Sci (Lond)
, vol.90
, pp. 37-46
-
-
Plumpton, C.1
Ashby, M.J.2
Kuc, R.E.3
O'Reilly, G.4
Davenport, A.P.5
-
120
-
-
84862817809
-
Place your BETs: The therapeutic potential of bromodomains
-
Prinjha RK, Witherington J, Lee K, (2012). Place your BETs: the therapeutic potential of bromodomains. Trends Pharmacol Sci 33: 146-153.
-
(2012)
Trends Pharmacol Sci
, vol.33
, pp. 146-153
-
-
Prinjha, R.K.1
Witherington, J.2
Lee, K.3
-
121
-
-
84883108940
-
Macitentan and morbidity and mortality in pulmonary arterial hypertension
-
Pulido T, Adzerikho I, Channick RN, Delcroix M, Galie N, Ghofrani HA, et al. (2013). Macitentan and morbidity and mortality in pulmonary arterial hypertension. N Engl J Med 369: 809-818.
-
(2013)
N Engl J Med
, vol.369
, pp. 809-818
-
-
Pulido, T.1
Adzerikho, I.2
Channick, R.N.3
Delcroix, M.4
Galie, N.5
Ghofrani, H.A.6
-
122
-
-
33744899835
-
B receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats
-
B receptor agonist, IRL-1620, on paclitaxel plasma pharmacokinetics of breast tumor rats. Exp Biol Med 231: 1120-1122.
-
(2006)
Exp Biol Med
, vol.231
, pp. 1120-1122
-
-
Rai, A.1
Rajeshkumar, N.V.2
Gulati, A.3
-
123
-
-
84918819375
-
Endothelin B receptor agonist, IRL 1620, a novel adjuvant to enhance the delivery and efficacy of paclitaxel in a rat mammary tumor model
-
Rajeshkumar NV, Rai A, Gulati A, (2005a). Endothelin B receptor agonist, IRL 1620, a novel adjuvant to enhance the delivery and efficacy of paclitaxel in a rat mammary tumor model. Clin Cancer Res 11: 9138S-9239S.
-
(2005)
Clin Cancer Res
, vol.11
, pp. 9138S-9239S
-
-
Rajeshkumar, N.V.1
Rai, A.2
Gulati, A.3
-
124
-
-
27944449731
-
Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats
-
Rajeshkumar NV, Rai A, Gulati A, (2005b). Endothelin B receptor agonist, IRL 1620, enhances the anti-tumor efficacy of paclitaxel in breast tumor rats. Breast Cancer Res Treat 94: 237-247.
-
(2005)
Breast Cancer Res Treat
, vol.94
, pp. 237-247
-
-
Rajeshkumar, N.V.1
Rai, A.2
Gulati, A.3
-
125
-
-
84885047361
-
Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis
-
Rattner A, Yu H, Williams J, Smallwood PM, Nathans J, (2013). Endothelin-2 signaling in the neural retina promotes the endothelial tip cell state and inhibits angiogenesis. Proc Natl Acad Sci U S A 110: E3830-E3839.
-
(2013)
Proc Natl Acad Sci U S A
, vol.110
, pp. E3830-E3839
-
-
Rattner, A.1
Yu, H.2
Williams, J.3
Smallwood, P.M.4
Nathans, J.5
-
127
-
-
0029069808
-
Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist
-
Reynolds EE, Keiser JA, Haleen SJ, Walker DM, Olszewski B, Schroeder RL, et al. (1995). Pharmacological characterization of PD 156707, an orally active ETA receptor antagonist. J Pharmacol Exp Ther 273: 1410-1417.
-
(1995)
J Pharmacol Exp Ther
, vol.273
, pp. 1410-1417
-
-
Reynolds, E.E.1
Keiser, J.A.2
Haleen, S.J.3
Walker, D.M.4
Olszewski, B.5
Schroeder, R.L.6
-
128
-
-
62449145673
-
β-Arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis
-
Rosanò L, Cianfrocca R, Masi S, Spinella F, Di Castro V, Biroccio A, et al. (2009). β-Arrestin links endothelin A receptor to beta-catenin signaling to induce ovarian cancer cell invasion and metastasis. Proc Natl Acad Sci U S A 106: 2806-2811.
-
(2009)
Proc Natl Acad Sci U S A
, vol.106
, pp. 2806-2811
-
-
Rosanò, L.1
Cianfrocca, R.2
Masi, S.3
Spinella, F.4
Di Castro, V.5
Biroccio, A.6
-
129
-
-
84886100276
-
β-Arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling
-
Rosanò L, Cianfrocca R, Tocci P, Spinella F, Di Castro V, Spadaro F, et al. (2013a). β-Arrestin-1 is a nuclear transcriptional regulator of endothelin-1-induced beta-catenin signaling. Oncogene 32: 5066-5077.
-
(2013)
Oncogene
, vol.32
, pp. 5066-5077
-
-
Rosanò, L.1
Cianfrocca, R.2
Tocci, P.3
Spinella, F.4
Di Castro, V.5
Spadaro, F.6
-
130
-
-
84883153220
-
Endothelin 1 in cancer: Biological implications and therapeutic opportunities
-
Rosanò L, Spinella F, Bagnato A, (2013b). Endothelin 1 in cancer: biological implications and therapeutic opportunities. Nat Rev Cancer 13: 637-651.
-
(2013)
Nat Rev Cancer
, vol.13
, pp. 637-651
-
-
Rosanò, L.1
Spinella, F.2
Bagnato, A.3
-
131
-
-
84867578454
-
Endothelin receptor antagonists for the treatment of pulmonary artery hypertension
-
Rubin LJ, (2012). Endothelin receptor antagonists for the treatment of pulmonary artery hypertension. Life Sci 91: 517-521.
-
(2012)
Life Sci
, vol.91
, pp. 517-521
-
-
Rubin, L.J.1
-
132
-
-
0037149718
-
Bosentan therapy for pulmonary arterial hypertension
-
Rubin LJ, Badesch DB, Barst RJ, et al. (2002). Bosentan therapy for pulmonary arterial hypertension. N Engl J Med 346: 896-903.
-
(2002)
N Engl J Med
, vol.346
, pp. 896-903
-
-
Rubin, L.J.1
Badesch, D.B.2
Barst, R.J.3
-
133
-
-
0029858496
-
Characterization of the binding of endothelin ETB selective ligands in human and rat heart
-
Russell FD, Davenport AP, (1996). Characterization of the binding of endothelin ETB selective ligands in human and rat heart. Br J Pharmacol 119: 631-636.
-
(1996)
Br J Pharmacol
, vol.119
, pp. 631-636
-
-
Russell, F.D.1
Davenport, A.P.2
-
134
-
-
0033617232
-
Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells
-
Russell FD, Davenport AP, (1999a). Evidence for intracellular endothelin-converting enzyme-2 expression in cultured human vascular endothelial cells. Circ Res 84: 891-896.
-
(1999)
Circ Res
, vol.84
, pp. 891-896
-
-
Russell, F.D.1
Davenport, A.P.2
-
135
-
-
0032940038
-
Secretory pathways in endothelin synthesis
-
Russell FD, Davenport AP, (1999b). Secretory pathways in endothelin synthesis. Br J Pharmacol 26: 391-398.
-
(1999)
Br J Pharmacol
, vol.26
, pp. 391-398
-
-
Russell, F.D.1
Davenport, A.P.2
-
136
-
-
0032504759
-
Human endothelial cell storage granules: A novel intracellular site for isoforms of the endothelin-converting enzyme
-
Russell FD, Skepper JN, Davenport AP, (1998a). Human endothelial cell storage granules: a novel intracellular site for isoforms of the endothelin-converting enzyme. Circ Res 83: 314-321.
-
(1998)
Circ Res
, vol.83
, pp. 314-321
-
-
Russell, F.D.1
Skepper, J.N.2
Davenport, A.P.3
-
137
-
-
0031890934
-
Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin
-
Russell FD, Skepper JN, Davenport AP, (1998b). Evidence using immunoelectron microscopy for regulated and constitutive pathways in the transport and release of endothelin. J Cardiovasc Pharmacol 31: 424-430.
-
(1998)
J Cardiovasc Pharmacol
, vol.31
, pp. 424-430
-
-
Russell, F.D.1
Skepper, J.N.2
Davenport, A.P.3
-
138
-
-
84867574271
-
Permissive role of endothelin receptors in tumor metastasis
-
Said N, Theodorescu D, (2012). Permissive role of endothelin receptors in tumor metastasis. Life Sci 91: 522-527.
-
(2012)
Life Sci
, vol.91
, pp. 522-527
-
-
Said, N.1
Theodorescu, D.2
-
139
-
-
0025605930
-
Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor
-
Sakurai T, Yanagisawa M, Takuwa Y, Miyazaki H, Kimura S, Goto K, et al. (1990). Cloning of a cDNA encoding a non-isopeptide-selective subtype of the endothelin receptor. Nature 348: 732-735.
-
(1990)
Nature
, vol.348
, pp. 732-735
-
-
Sakurai, T.1
Yanagisawa, M.2
Takuwa, Y.3
Miyazaki, H.4
Kimura, S.5
Goto, K.6
-
140
-
-
84867574381
-
The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans
-
Seed A, Kuc RE, Maguire JJ, Hillier C, Johnston F, Essers H, et al. (2012). The dual endothelin converting enzyme/neutral endopeptidase inhibitor SLV-306 (daglutril), inhibits systemic conversion of big endothelin-1 in humans. Life Sci 91: 743-748.
-
(2012)
Life Sci
, vol.91
, pp. 743-748
-
-
Seed, A.1
Kuc, R.E.2
Maguire, J.J.3
Hillier, C.4
Johnston, F.5
Essers, H.6
-
141
-
-
42149140537
-
Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1
-
Seyrantepe V, Hinek A, Peng J, Fedjaev M, Ernest S, Kadota Y, et al. (2008). Enzymatic activity of lysosomal carboxypeptidase (cathepsin) A is required for proper elastic fiber formation and inactivation of endothelin-1. Circulation 117: 1973-1981.
-
(2008)
Circulation
, vol.117
, pp. 1973-1981
-
-
Seyrantepe, V.1
Hinek, A.2
Peng, J.3
Fedjaev, M.4
Ernest, S.5
Kadota, Y.6
-
142
-
-
80051766443
-
Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage
-
Sharkovska Y, Kalk P, von Websky K, Relle K, Pfab T, Alter M, et al. (2011). Renoprotective effects of combined endothelin-converting enzyme/neutral endopeptidase inhibitor SLV338 in acute and chronic experimental renal damage. Clin Lab 57: 507-515.
-
(2011)
Clin Lab
, vol.57
, pp. 507-515
-
-
Sharkovska, Y.1
Kalk, P.2
Von Websky, K.3
Relle, K.4
Pfab, T.5
Alter, M.6
-
143
-
-
80054771944
-
Macitentan: Entry-into-humans study with a new endothelin receptor antagonist
-
Sidharta PN, van Giersbergen PL, Halabi A, Dingemanse J, (2011). Macitentan: entry-into-humans study with a new endothelin receptor antagonist. Eur J Clin Pharmacol 67: 977-984.
-
(2011)
Eur J Clin Pharmacol
, vol.67
, pp. 977-984
-
-
Sidharta, P.N.1
Van Giersbergen, P.L.2
Halabi, A.3
Dingemanse, J.4
-
144
-
-
84898645285
-
Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment
-
Sidharta PN, Lindegger N, Ulc I, Dingemanse J, (2013a). Pharmacokinetics of the novel dual endothelin receptor antagonist macitentan in subjects with hepatic or renal impairment. J Clin Pharmacol 55: 291-300.
-
(2013)
J Clin Pharmacol
, vol.55
, pp. 291-300
-
-
Sidharta, P.N.1
Lindegger, N.2
Ulc, I.3
Dingemanse, J.4
-
145
-
-
84898645285
-
Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects
-
Sidharta PN, van Giersbergen PL, Dingemanse J, (2013b). Safety, tolerability, pharmacokinetics, and pharmacodynamics of macitentan, an endothelin receptor antagonist, in an ascending multiple-dose study in healthy subjects. J Clin Pharmacol 54: 291-300.
-
(2013)
J Clin Pharmacol
, vol.54
, pp. 291-300
-
-
Sidharta, P.N.1
Van Giersbergen, P.L.2
Dingemanse, J.3
-
146
-
-
0025321142
-
Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: Possible physiological significance
-
Skolovsky M, Galron R, Kloog Y, Bdolah A, Indig FE, Blumberg S, et al. (1990). Endothelins are more sensitive than sarafotoxins to neutral endopeptidase: possible physiological significance. Proc Natl Acad Sci U S A 87: 4702-4706.
-
(1990)
Proc Natl Acad Sci U S A
, vol.87
, pp. 4702-4706
-
-
Skolovsky, M.1
Galron, R.2
Kloog, Y.3
Bdolah, A.4
Indig, F.E.5
Blumberg, S.6
-
147
-
-
84878913517
-
Endothelin, kidney disease, and hypertension
-
Speed JS, Pollock DM, (2013). Endothelin, kidney disease, and hypertension. Hypertension 61: 1142-1145.
-
(2013)
Hypertension
, vol.61
, pp. 1142-1145
-
-
Speed, J.S.1
Pollock, D.M.2
-
148
-
-
0023946168
-
Sarafotoxins S6: Several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart
-
Takasaki C, Tamiya N, Bdolah A, Wollberg Z, Kochva E, (1988). Sarafotoxins S6: several isotoxins from Atractaspis engaddensis (burrowing asp) venom that affect the heart. Toxicon 26: 543-548.
-
(1988)
Toxicon
, vol.26
, pp. 543-548
-
-
Takasaki, C.1
Tamiya, N.2
Bdolah, A.3
Wollberg, Z.4
Kochva, E.5
-
149
-
-
0026764085
-
A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor
-
Takai M, Umemura I, Yamasaki K, Watakabe T, Fujitani Y, Oda K, et al. (1992). A potent and specific agonist, Suc-[Glu9,Ala11,15]-endothelin-1(8-21), IRL 1620, for the ETB receptor. Biochem Biophys Res Commun 184: 953-959.
-
(1992)
Biochem Biophys Res Commun
, vol.184
, pp. 953-959
-
-
Takai, M.1
Umemura, I.2
Yamasaki, K.3
Watakabe, T.4
Fujitani, Y.5
Oda, K.6
-
150
-
-
27644437349
-
Differential expression of endothelin-2 along the mouse intestinal tract
-
Takizawa S, Uchide T, Adur J, Kozakai T, Kotake-Nara E, Quan J, et al. (2005). Differential expression of endothelin-2 along the mouse intestinal tract. J Mol Endocrinol 35: 201-209.
-
(2005)
J Mol Endocrinol
, vol.35
, pp. 201-209
-
-
Takizawa, S.1
Uchide, T.2
Adur, J.3
Kozakai, T.4
Kotake-Nara, E.5
Quan, J.6
-
151
-
-
11144267307
-
Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats
-
Thone-Reinke C, Simon K, Richter CM, Godes M, Neumayer HH, Thormahlen D, et al. (2004). Inhibition of both neutral endopeptidase and endothelin-converting enzyme by SLV306 reduces proteinuria and urinary albumin excretion in diabetic rats. J Cardiovasc Pharmacol 44: S76-S79.
-
(2004)
J Cardiovasc Pharmacol
, vol.44
, pp. S76-S79
-
-
Thone-Reinke, C.1
Simon, K.2
Richter, C.M.3
Godes, M.4
Neumayer, H.H.5
Thormahlen, D.6
-
152
-
-
0030032386
-
Molecular pharmacology of endothelin converting enzymes
-
Turner AJ, Murphy LJ, (1996). Molecular pharmacology of endothelin converting enzymes. Biochem Pharmacol 26: 91-102.
-
(1996)
Biochem Pharmacol
, vol.26
, pp. 91-102
-
-
Turner, A.J.1
Murphy, L.J.2
-
153
-
-
0030899822
-
Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX
-
Turner AJ, Tanzawa K, (1997). Mammalian membrane metallopeptidases: NEP, ECE, KELL, and PEX. FASEB J 11: 355-364.
-
(1997)
FASEB J
, vol.11
, pp. 355-364
-
-
Turner, A.J.1
Tanzawa, K.2
-
154
-
-
0035112440
-
The neprilysin (NEP) family of zinc metalloendopeptidases: Genomics and function
-
Turner AJ, Isaac RE, Coates D, (2001). The neprilysin (NEP). family of zinc metalloendopeptidases: genomics and function. Bioessays 23: 261-269.
-
(2001)
Bioessays
, vol.23
, pp. 261-269
-
-
Turner, A.J.1
Isaac, R.E.2
Coates, D.3
-
155
-
-
34247847802
-
Ambrisentan, a non-peptide endothelin receptor antagonist
-
Vatter H, Seifert V, (2006). Ambrisentan, a non-peptide endothelin receptor antagonist. Cardiovasc Drug Rev 24: 63-76.
-
(2006)
Cardiovasc Drug Rev
, vol.24
, pp. 63-76
-
-
Vatter, H.1
Seifert, V.2
-
156
-
-
84867574237
-
Endothelin and endothelin receptors in the renal and cardiovascular systems
-
Vignon-Zellweger N, Heiden S, Miyauchi T, Emoto N, (2012). Endothelin and endothelin receptors in the renal and cardiovascular systems. Life Sci 91: 490-500.
-
(2012)
Life Sci
, vol.91
, pp. 490-500
-
-
Vignon-Zellweger, N.1
Heiden, S.2
Miyauchi, T.3
Emoto, N.4
-
157
-
-
84872847300
-
Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer
-
Wang R, Lohr CV, Fischer K, Dashwood WM, Greenwood JA, Ho E, et al. (2013). Epigenetic inactivation of endothelin-2 and endothelin-3 in colon cancer. Int J Cancer 132: 1004-1012.
-
(2013)
Int J Cancer
, vol.132
, pp. 1004-1012
-
-
Wang, R.1
Lohr, C.V.2
Fischer, K.3
Dashwood, W.M.4
Greenwood, J.A.5
Ho, E.6
-
158
-
-
0029065161
-
Endogenous endothelin generation maintains vascular tone in humans
-
Webb DJ, (1995). Endogenous endothelin generation maintains vascular tone in humans. J Hum Hypertens 9: 459-463.
-
(1995)
J Hum Hypertens
, vol.9
, pp. 459-463
-
-
Webb, D.J.1
-
159
-
-
84873713624
-
Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro
-
Weiss J, Theile D, Ruppell MA, Speck T, Spalwisz A, Haefeli WE, (2013). Interaction profile of macitentan, a new non-selective endothelin-1 receptor antagonist, in vitro. Eur J Pharmacol 701: 168-175.
-
(2013)
Eur J Pharmacol
, vol.701
, pp. 168-175
-
-
Weiss, J.1
Theile, D.2
Ruppell, M.A.3
Speck, T.4
Spalwisz, A.5
Haefeli, W.E.6
-
160
-
-
84871583767
-
Early progress in epigenetic regulation of endothelin pathway genes
-
Welch AK, Jacobs ME, Wingo CS, Cain BD, (2013). Early progress in epigenetic regulation of endothelin pathway genes. Br J Pharmacol 168: 327-334.
-
(2013)
Br J Pharmacol
, vol.168
, pp. 327-334
-
-
Welch, A.K.1
Jacobs, M.E.2
Wingo, C.S.3
Cain, B.D.4
-
161
-
-
79951893913
-
Novel therapy approach in primary stroke prevention: Simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival
-
Wengenmayer C, Krikov M, Mueller S, Lucht K, Villringer A, Hocher B, et al. (2011). Novel therapy approach in primary stroke prevention: simultaneous inhibition of endothelin converting enzyme and neutral endopeptidase in spontaneously hypertensive, stroke-prone rats improves survival. Neurol Res 33: 201-207.
-
(2011)
Neurol Res
, vol.33
, pp. 201-207
-
-
Wengenmayer, C.1
Krikov, M.2
Mueller, S.3
Lucht, K.4
Villringer, A.5
Hocher, B.6
-
162
-
-
0025823462
-
Sarafotoxin S6c, an agonist which distinguishes between endothelin receptor subtypes
-
William DL, Jones KL, Pettibone DJ, Lis EV, Clineschmidt BV, (1991). Sarafotoxin S6c, an agonist which distinguishes between endothelin receptor subtypes. Biochem Biophys Res Commun 175: 556-561.
-
(1991)
Biochem Biophys Res Commun
, vol.175
, pp. 556-561
-
-
William, D.L.1
Jones, K.L.2
Pettibone, D.J.3
Lis, E.V.4
Clineschmidt, B.V.5
-
163
-
-
0027992642
-
ECE-1: A membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1
-
Xu D, Emoto N, Giaid A, Slaughter C, Kaw S, deWit D, et al. (1994). ECE-1: a membrane-bound metalloprotease that catalyzes the proteolytic activation of big endothelin-1. Cell 78: 473-485.
-
(1994)
Cell
, vol.78
, pp. 473-485
-
-
Xu, D.1
Emoto, N.2
Giaid, A.3
Slaughter, C.4
Kaw, S.5
Dewit, D.6
-
164
-
-
84873607949
-
Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: Epigenetics in PAH following IUGR
-
Xu XF, Lv Y, Gu WZ, Tang LL, Wei JK, Zhang LY, et al. (2013). Epigenetics of hypoxic pulmonary arterial hypertension following intrauterine growth retardation rat: epigenetics in PAH following IUGR. Respir Res 14: 20.
-
(2013)
Respir Res
, vol.14
, pp. 20
-
-
Xu, X.F.1
Lv, Y.2
Gu, W.Z.3
Tang, L.L.4
Wei, J.K.5
Zhang, L.Y.6
-
165
-
-
0031940499
-
Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene
-
Yanagisawa H, Yanagisawa M, Kapur RP, Richardson JA, Williams SC, Clouthier DE, et al. (1998). Dual genetic pathways of endothelin-mediated intercellular signaling revealed by targeted disruption of endothelin converting enzyme-1 gene. Development 125: 825-836.
-
(1998)
Development
, vol.125
, pp. 825-836
-
-
Yanagisawa, H.1
Yanagisawa, M.2
Kapur, R.P.3
Richardson, J.A.4
Williams, S.C.5
Clouthier, D.E.6
-
166
-
-
0034086055
-
Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development
-
Yanagisawa H, Hammer RE, Richardson JA, Emoto N, Williams SC, Takeda SI, et al. (2000). Disruption of ECE-1 and ECE-2 reveals a role for endothelin-converting enzyme-2 in murine cardiac development. J Clin Invest 105: 1373-1382.
-
(2000)
J Clin Invest
, vol.105
, pp. 1373-1382
-
-
Yanagisawa, H.1
Hammer, R.E.2
Richardson, J.A.3
Emoto, N.4
Williams, S.C.5
Takeda, S.I.6
-
167
-
-
0012576401
-
Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide
-
Yanagisawa M, Inoue A, Ishikawa T, Kasuya Y, Kimura S, Kumagaye S, et al. (1988). Primary structure, synthesis, and biological activity of rat endothelin, an endothelium-derived vasoconstrictor peptide. Proc Natl Acad Sci U S A 85: 6964-6967.
-
(1988)
Proc Natl Acad Sci U S A
, vol.85
, pp. 6964-6967
-
-
Yanagisawa, M.1
Inoue, A.2
Ishikawa, T.3
Kasuya, Y.4
Kimura, S.5
Kumagaye, S.6
-
168
-
-
0033983604
-
Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi
-
Yap EY, Battistini B, McKay KO, (2000). Contraction to big endothelin-1, big endothelin-2 and big endothelin-3, and endothelin-converting enzyme inhibition in human isolated bronchi. Br J Pharmacol 129: 170-176.
-
(2000)
Br J Pharmacol
, vol.129
, pp. 170-176
-
-
Yap, E.Y.1
Battistini, B.2
McKay, K.O.3
-
169
-
-
84918791522
-
Characterisation of the 'endothelin-like domain peptide' (ELDP) co-synthesised with endothelin-1 from the EDN1 gene
-
Yuzgulen J, Wood EG, Villar IC, Douthwaite JA, Patel NSA, Jegard J, et al. (2013). Characterisation of the 'endothelin-like domain peptide' (ELDP) co-synthesised with endothelin-1 from the EDN1 gene. Life Sciences 93: DOI: 10.1016/j.lfs.2013.12.037.
-
(2013)
Life Sciences
, vol.93
-
-
Yuzgulen, J.1
Wood, E.G.2
Villar, I.C.3
Douthwaite, J.A.4
Patel, N.S.A.5
Jegard, J.6
-
170
-
-
0033609028
-
Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure
-
Zolk O, Quattek J, Sitzler G, Schrader T, Nickenig G, Schnabel P, et al. (1999). Expression of endothelin-1, endothelin-converting enzyme, and endothelin receptors in chronic heart failure. Circulation 99: 2118-2123.
-
(1999)
Circulation
, vol.99
, pp. 2118-2123
-
-
Zolk, O.1
Quattek, J.2
Sitzler, G.3
Schrader, T.4
Nickenig, G.5
Schnabel, P.6
|